All articles tagged with #metastatic prostate cancer
Scott Adams, the creator of Dilbert, died at 68 after being diagnosed with metastatic prostate cancer, with the news announced by his former wife in a livestream on X; he had been in hospice care in Northern California and had previously faced controversy over racist remarks that led many publications to drop Dilbert before it was relaunched online as Dilbert Reborn.
Scott Adams, the creator of Dilbert, died at 68 after a battle with metastatic prostate cancer. His career rose from a comic strip that mocked corporate culture to a broader media presence, but he later faced severe backlash in 2023 over remarks critics called racist, leading to multiple outlets dropping Dilbert and his publisher severing ties. He continued an active online presence with daily livestreams and wrote several books, including Win Bigly and How to Fail at Almost Everything and Still Win Big.
The article discusses the complexities of screening and treating metastatic prostate cancer in men over 70, highlighting that while routine PSA testing is generally not recommended due to slow disease progression and potential treatment side effects, individual decisions should be made based on health status. It covers modern diagnostic tools like MRI and PSMA scans, advances in treatment such as hormone therapy, chemotherapy, and targeted radiation, and emphasizes that recent progress has improved survival rates and management of the disease in older men.
Novartis' therapy for metastatic prostate cancer, Pluvicto, has shown potential benefits as a treatment before chemotherapy, according to Phase 3 data presented at the European Society for Medical Oncology. The trial enrolled patients with metastatic prostate cancer who had previously taken an androgen receptor pathway inhibitor, and the results highlight the effectiveness of radiation-delivering cancer therapies. Novartis' investment in this field is attracting interest from other pharmaceutical companies.